GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 09, 2022
Share
GeneFerm Biotechnology Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 153.72 million compared to TWD 120.95 million a year ago. Net income was TWD 30.02 million compared to TWD 10.4 million a year ago. Basic earnings per share from continuing operations was TWD 0.72 compared to TWD 0.26 a year ago. Diluted earnings per share from continuing operations was TWD 0.72 compared to TWD 0.24 a year ago.
For the six months, sales was TWD 297.63 million compared to TWD 234.82 million a year ago. Net income was TWD 50.52 million compared to TWD 21.74 million a year ago. Basic earnings per share from continuing operations was TWD 1.23 compared to TWD 0.56 a year ago. Diluted earnings per share from continuing operations was TWD 1.17 compared to TWD 0.53 a year ago.
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.